|
Jan, 2010 | Pages : 85 | Price : US$ 1000.00 |
| It is expected that Indian healthcare market will grow at a CAGR of around 21% during 2010-2013. |
| |
|
Dec, 2009 | Pages : 45 | Price : US$ 1000.00 |
| With continuous increase in demand, the industry is expected to witness growth of around 8% in 2009 over the previous year. |
| |
|
Dec, 2009 | Pages : 130 | Price : US$ 1500.00 |
| The pharmaceutical market in the above mentioned emerging countries is projected to grow at a CAGR of around 14.7% during 2009-2012. |
| |
|
Dec, 2009 | Pages : 170 | Price : US$ 1800.00 |
| The global pharma industry is projected to grow at a CAGR of around 6% during 2010-2012. The growth will be driven by low cost factor. |
| |
|
Nov, 2009 | Pages : 100 | Price : US$ 1200.00 |
| The future of pharma industry in the Asia-Pacific region remains bright, and the industry is projected to grow at a CAGR of around 12.6% during 2010-2012. |
| |
|
Nov, 2009 | Pages : 55 | Price : US$ 1100.00 |
| The biotech market in Malaysia is expected to grow at a CAGR of around 21% during 2010-2012. |
| |
|
Nov, 2009 | Pages : 55 | Price : US$ 1000.00 |
| The US represents the world’s largest healthcare market, with an annual spending of around US$ 2.24 Trillion in 2007. The US healthcare spending is expected to grow at a CAGR of around 4%. |
| |
|
Oct, 2009 | Pages : 105 | Price : US$ 1200.00 |
| The Chinese healthcare spending is forecast to grow at CAGR of over 18% during 2010-2012. The market is characterized by major changes in rural healthcare infrastructure. |
| |
|
Sep, 2009 | Pages : 85 | Price : US$ 1200.00 |
| The clinical trial outsourced market in India is forecasted to grow at a CAGR of around 31% during 2010-2012. Presently, the market is characterized by the dominance of phase III and phase II trials, |
| |
|
Sep, 2009 | Pages : 70 | Price : US$ 1200.00 |
| The pharmaceutical market in the region is expected to grow at a CAGR of around 11% during 2010-2012. Presently, the market is characterized by major changes in regulation policies of every country. |
| |
|
|
